144 related articles for article (PubMed ID: 16782344)
1. A flexible approach for the preparation of substituted benzazepines: application to the synthesis of tolvaptan.
Cordero-Vargas A; Quiclet-Sire B; Zard SZ
Bioorg Med Chem; 2006 Sep; 14(18):6165-73. PubMed ID: 16782344
[TBL] [Abstract][Full Text] [Related]
2. Concise synthesis of 2-benzazepine derivatives and their biological activity.
So M; Kotake T; Matsuura K; Inui M; Kamimura A
J Org Chem; 2012 Apr; 77(8):4017-28. PubMed ID: 22463127
[TBL] [Abstract][Full Text] [Related]
3. Preparation of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetamide derivatives as novel arginine vasopressin V(2) receptor agonists.
Tsukamoto I; Koshio H; Akamatsu S; Kuramochi T; Saitoh C; Yatsu T; Yanai-Inamura H; Kitada C; Yamamoto E; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Nov; 16(21):9524-35. PubMed ID: 18835174
[TBL] [Abstract][Full Text] [Related]
4. Identification and synthesis of major metabolites of Vasopressin V2-receptor agonist WAY-151932, and antagonist, Lixivaptan.
Molinari AJ; Trybulski EJ; Bagli J; Croce S; Considine J; Qi J; Ali K; Demaio W; Lihotz L; Cochran D
Bioorg Med Chem Lett; 2007 Nov; 17(21):5796-800. PubMed ID: 17855087
[TBL] [Abstract][Full Text] [Related]
5. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part 2: [g]-fused and hetero-fused systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Damiani F; Di Fabio R; Donati D; Gentile G; Hamprecht D; Perini O; Petrone M; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):908-12. PubMed ID: 18178090
[TBL] [Abstract][Full Text] [Related]
6. Solid-phase preparation of a pilot library derived from the 2,3,4,5-tetrahydro-1H-benzo[b]azepin-5-amine scaffold.
Boeglin D; Bonnet D; Hibert M
J Comb Chem; 2007; 9(3):487-500. PubMed ID: 17358083
[TBL] [Abstract][Full Text] [Related]
7. New fused benzazepine as selective D3 receptor antagonists. Synthesis and biological evaluation. Part one: [h]-fused tricyclic systems.
Micheli F; Bonanomi G; Braggio S; Capelli AM; Celestini P; Damiani F; Di Fabio R; Donati D; Gagliardi S; Gentile G; Hamprecht D; Petrone M; Radaelli S; Tedesco G; Terreni S; Worby A; Heidbreder C
Bioorg Med Chem Lett; 2008 Feb; 18(3):901-7. PubMed ID: 18248991
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of novel 4,4-difluorobenzazepine derivatives as non-peptide antagonists of the arginine vasopressin V1A receptor.
Shimada Y; Taniguchi N; Matsuhisa A; Akane H; Kawano N; Suzuki T; Tobe T; Kakefuda A; Yatsu T; Tahara A; Tomura Y; Kusayama T; Wada K; Tsukada J; Orita M; Tsunoda T; Tanaka A
Bioorg Med Chem; 2006 Mar; 14(6):1827-37. PubMed ID: 16290163
[TBL] [Abstract][Full Text] [Related]
9. Atropisomerism in the vaptan class of vasopressin receptor ligands: the active conformation recognized by the receptor.
Tabata H; Nakagomi J; Morizono D; Oshitari T; Takahashi H; Natsugari H
Angew Chem Int Ed Engl; 2011 Mar; 50(13):3075-9. PubMed ID: 21404400
[No Abstract] [Full Text] [Related]
10. C-H insertion processes on stabilized indolyl and ortho-aminophenyl Fischer carbene complexes: synthesis of azepino[3,2,1-hi] indole, benzazepine and indole derivatives.
Barluenga J; Fañanás-Mastral M; Aznar F
Chemistry; 2008; 14(25):7508-12. PubMed ID: 18668499
[No Abstract] [Full Text] [Related]
11. An efficient preparation of N-alkyl-2-benzazepine derivatives and investigation of their biological activity.
Kamimura A; So M; Kuratani T; Matsuura K; Inui M
Bioorg Med Chem Lett; 2009 Jun; 19(12):3193-5. PubMed ID: 19442522
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and structure-activity relationships of a series of benzazepine derivatives as 5-HT2C receptor agonists.
Shimada I; Maeno K; Kondoh Y; Kaku H; Sugasawa K; Kimura Y; Hatanaka K; Naitou Y; Wanibuchi F; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2008 Mar; 16(6):3309-20. PubMed ID: 18083579
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationships of amide derivatives of (4,4-difluoro-1,2,3,4-tetrahydro-5H-1-benzazepin-5-ylidene)acetic acid as selective arginine vasopressin V2 receptor agonists.
Tsukamoto I; Koshio H; Kuramochi T; Saitoh C; Yanai-Inamura H; Kitada-Nozawa C; Yamamoto E; Yatsu T; Shimada Y; Sakamoto S; Tsukamoto S
Bioorg Med Chem; 2009 Apr; 17(8):3130-41. PubMed ID: 19321349
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of 6-substituted 1-phenylbenzazepines and their dopamine D(1) receptor activities.
Zhang J; Chen X; Yu L; Zhen X; Zhang A
Bioorg Med Chem; 2008 Nov; 16(21):9425-31. PubMed ID: 18835172
[TBL] [Abstract][Full Text] [Related]
15. Efficient synthesis of the 3-benzazepine framework via intramolecular Heck reductive cyclization.
Donets PA; Van der Eycken EV
Org Lett; 2007 Aug; 9(16):3017-20. PubMed ID: 17608431
[TBL] [Abstract][Full Text] [Related]
16. Tolvaptan, an orally active vasopressin V(2)-receptor antagonist - pharmacology and clinical trials.
Miyazaki T; Fujiki H; Yamamura Y; Nakamura S; Mori T
Cardiovasc Drug Rev; 2007; 25(1):1-13. PubMed ID: 17445084
[TBL] [Abstract][Full Text] [Related]
17. A new structural motif for mu-opioid antagonists.
Van den Eynde I; Laus G; Schiller PW; Kosson P; Chung NN; Lipkowski AW; Tourwé D
J Med Chem; 2005 May; 48(10):3644-8. PubMed ID: 15887972
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of 1-benzothiepine and 1-benzazepine derivatives as orally active CCR5 antagonists.
Aramaki Y; Seto M; Okawa T; Oda T; Kanzaki N; Shiraishi M
Chem Pharm Bull (Tokyo); 2004 Feb; 52(2):254-8. PubMed ID: 14758013
[TBL] [Abstract][Full Text] [Related]
19. Tolvaptan-Type Vasopressin Receptor Ligands: Important Role of Axial Chirality in the Active Form.
Tabata H; Yoneda T; Oshitari T; Takahashi H; Natsugari H
J Med Chem; 2017 May; 60(10):4503-4509. PubMed ID: 28475329
[TBL] [Abstract][Full Text] [Related]
20. Dynamic thermodynamic resolution: solvent effects, mechanism, and an asymmetric 3,4,5-substituted benzazepine synthesis.
Park YS; Yum EK; Basu A; Beak P
Org Lett; 2006 Jun; 8(13):2667-70. PubMed ID: 16774227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
